Imipramine Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Imipramine Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING




Suicidality and Antidepressant Drugs
Warnings: Clinical Worsening and Suicide RiskPrecautions: Information for PatientsPrecautions: Pediatric Use

IMIPRAMINE HYDROCHLORIDE DESCRIPTION









CLINICAL PHARMACOLOGY



INDICATIONS & USAGE

Depression


Childhood Enuresis


IMIPRAMINE HYDROCHLORIDE CONTRAINDICATIONS




WARNINGS

Clinical Worsening and Suicide Risk



AgeDrug-Placebo Difference in Number of Cases of Suicidality perRange1000 Patients Treated






Screening Patients for Bipolar Disorder


Children


  • ●patients with increased intraocular pressure, history of urinary retention, or history of narrow-angle glaucoma because of the drug's anticholinergic properties;
  • ●hyperthyroid patients or those on thyroid medication because of the possibility of cardiovascular toxicity;
  • ●patients with a history of seizure disorder because this drug has been shown to lower the seizure threshold;
  • ●patients receiving guanethidine, clonidine, or similar agents, since imipramine may block the pharmacologic effects of these drugs;
  • ●patients receiving methylphenidate hydrochloride. Since methylphenidate hydrochloride may inhibit the metabolism of imipramine hydrochloride, downward dosage adjustment of imipramine hydrochloride may be required when given concomitantly with methylphenidate hydrochloride.
  • ●Imipramine may enhance the CNS depressant effects of alcohol. Therefore, it should be borne in mind that the dangers inherent in a suicide attempt or accidental overdosage with the drug may be increased for the patient who uses excessive amounts of alcohol. (SeePRECAUTIONS.)


PRECAUTIONS

Information for Patients



Clinical Worsening and Suicide Risk


General
WARNINGS









DRUG INTERACTIONS

Drugs Metabolized by P450 2D6






WARNINGS

PREGNANCY

ANIMAL PHARMACOLOGY & TOXICOLOGY


NURSING MOTHERS



PEDIATRIC USE

BOX WARNINGWARNINGSClinical Worsening and Suicide Risk



GERIATRIC USE



DOSAGE AND ADMINISTRATION
PRECAUTIONS General

IMIPRAMINE HYDROCHLORIDE ADVERSE REACTIONS






OVERDOSAGE




Manifestations




Management


Gastrointestinal Decontamination


Cardiovascular



CNS


Psychiatric Follow-up


Pediatric Management


DOSAGE & ADMINISTRATION

Depression


Usual Adult Dose




Childhood Enuresis




HOW SUPPLIED







STORAGE AND HANDLING





ANIMAL PHARMACOLOGY & OR TOXICOLOGY

A. Acute





B. Reproduction/Teratogenic









SPL MEDGUIDE



  • ●all risks and benefits of treatment with antidepressant medicines
  • ●all treatment choices for depression or other serious mental illness
  • ●What is the most important information I should know about antidepressant medicines, depression and other serious mental illnesses, and suicidal thoughts or actions?




  • ●Call the healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings.
  • ●Keep all follow-up visits with the healthcare provider as scheduled. Call the healthcare provider between visits as needed, especially if you have concerns about symptoms.
  • ●Call a healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you:

  • ●attempts to commit suicide
  • ●new or worse depression
  • ●new or worse anxiety
  • ●feeling very agitated or restless
  • ●panic attacks
  • ●trouble sleeping (insomnia)
  • ●new or worse irritability
  • ●acting aggressive, being angry, or violent
  • ●acting on dangerous impulses
  • ●an extreme increase in activity and talking (mania)
  • ●other unusual changes in behavior or mood
  • ●What else do I need to know about antidepressant medicines?

  • ●Antidepressants are medicines used to treat depression and other illnesses. It is important to discuss all the risks of treating depression and also the risks of not treating it. Patients and their families or other caregivers should discuss all treatment choices with the healthcare provider, not just the use of antidepressants.
  • ●Antidepressant medicines have other side effects. Talk to the healthcare provider about the side effects of the medicine prescribed for you or your family member.
  • ●Antidepressant medicines can interact with other medicines. Know all of the medicines that you or your family member takes. Keep a list of all medicines to show the healthcare provider. Do not start new medicines without first checking with your health care provider.
  • ●Not all antidepressant medicines prescribed for children are FDA approved for use in children. Talk to your child's healthcare provider for more information.
  • ●This Medication Guide has been approved by the U.S. Food and Drug Administration for all antidepressants.


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Imipramine Hydrochloride



Imipramine Hydrochloride






Imipramine Hydrochloride

Imipramine Hydrochloride TABLET, FILM COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-207(NDC:53489-331)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
IMIPRAMINE HYDROCHLORIDE Imipramine 25 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
D&C YELLOW NO. 10
ALUMINUM OXIDE
FD&C BLUE NO. 1
FD&C YELLOW NO. 6
hydroxypropyl cellulose
MAGNESIUM STEARATE
cellulose, microcrystalline
polyethylene glycol
polysorbate 80
SODIUM STARCH GLYCOLATE TYPE A POTATO
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
brown 7 mm MP;8 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-207-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA081049 2011-04-21


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.